Research Papers

25 of 115 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Role of PET/CT in diagnosing and monitoring disease activity in rheumatoid arthritis: a review.
Singh SB; Bhandari S; Bhandari S; Bhandari S; Singh R; Raynor WY; Hess S; Werner TJ; Alavi A; Revheim ME.
Ann Nucl Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Visualization of small brain nuclei with a high-spatial resolution, clinically available whole-body PET scanner.
Shinohara Y; Ibaraki M; Matsubara K; Sato K; Yamamoto H; Kinoshita T.
Ann Nucl Med (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The quest for multifunctional and dedicated PET instrumentation with irregular geometries.
Sanaat A; Amini M; Arabi H; Zaidi H.
Ann Nucl Med (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
High efficacy of particle beam therapies against tumors under hypoxia and prediction of the early stage treatment effec…
Makino A; Kume K; Mori T; Tsujikawa T; Asai T; Okazawa H; Kiyono Y.
Ann Nucl Med (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Practice recommendation for measuring washout rates in <sup>123</sup>I-BMIPP fatty acid images.
Nakajima K; Miyauchi H; Hirano KI; Fujimoto S; Kawahito M; Iimori T; Kudo T.
Ann Nucl Med (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects.
Miyamoto M; Okuyama C; Kagawa S; Kusano K; Takahashi M; Takahata K; Jang MK; Yamauchi H.
Ann Nucl Med (Unknown)
Published: 2023
3/6 Transparent
Registered
Quantitative comparative analysis of amyloid PET images using three radiopharmaceuticals.
Jeong YJ; Yoon HJ; Kang DY; Park KW.
Ann Nucl Med (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Effect of scan-time shortening on the <sup>11</sup>C-PHNO binding potential to dopamine D<sub>3</sub> receptor in human…
Matsunaga K; Tonomura M; Abe K; Shimosegawa E.
Ann Nucl Med (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Prognostic value of semi-quantitative parameters of <sup>18</sup>F-FDG PET/CT in newly diagnosed multiple myeloma patie…
Wan B; Zhang S; Wang P; Deng P; Dai W.
Ann Nucl Med (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Added prognostic value of molecular imaging parameters over proliferation index in typical lung carcinoid: an [18F]FDG …
Linguanti F; Abenavoli EM; Briganti V; Danti G; Lavacchi D; Matteini M; Vaggelli L; Novelli L; Grosso AM; Mungai F; Mini E; Antonuzzo L; Miele V; Sciagrà R; Berti V.
Ann Nucl Med (Unknown)
Published: 2022
2/6 Transparent
Funding Declared
Metabolic tumor volume predicts long-term survival after transplantation for unresectable colorectal liver metastases: …
Grut H; Line PD; Syversveen T; Dueland S.
Ann Nucl Med (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer's disease.
Imabayashi E; Tamamura N; Yamaguchi Y; Kamitaka Y; Sakata M; Ishii K.
Ann Nucl Med (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Manual on the proper use of meta-[<sup>211</sup>At] astato-benzylguanidine ([<sup>211</sup>At] MABG) injections in clin…
Ukon N; Higashi T; Hosono M; Kinuya S; Yamada T; Yanagida S; Namba M; Nakamura Y.
Ann Nucl Med (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
F18-FDG PET/CT imaging early predicts pathologic complete response to induction chemoimmunotherapy of locally advanced …
Beck M; Hartwich J; Eckstein M; Schmidt D; Gostian AO; Müller S; Rutzner S; Gaipl US; von der Grün J; Illmer T; Hautmann MG; Klautke G; Döscher J; Brunner T; Tamaskovics B; Hartmann A; Iro H; Kuwert T; Fietkau R; Hecht M; Semrau S.
Ann Nucl Med (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Time point-independent tumor positivity of <sup>68</sup>Ga-PSMA-PET/CT pre- and post-biopsy in high-risk prostate cance…
Zou S; Song S; Zhou J; Yu B; Kuang D; Wang Z; Zhu X.
Ann Nucl Med (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
18F-FDG PET/CT as predictive and prognostic factor in esophageal cancer treated with combined modality treatment.
Krengli M; Ferrara E; Guaschino R; Puta E; Turri L; Luciani I; Sacchetti GM; Franco P; Brambilla M.
Ann Nucl Med (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Myocardial perfusion quantification with Rb-82 PET: good interobserver agreement of Carimas software on global, regiona…
Nesterov SV; Deshayes E; Juarez-Orozco LE; deKemp RA; Sciagrà R; Malaspina S; Settimo L; Han C; Ryzhkova DV; Kostina IS; Gwet KL; Prior JO; Knuuti JM.
Ann Nucl Med (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Influence of antidepressant use on <sup>123</sup>I-MIBG heart and lung uptakes in the diagnosis of Lewy body disease.
Adaniya S; Takahashi M; Koyama K; Ogane K; Momose T.
Ann Nucl Med (Unknown)
Published: 2022
2/6 Transparent
[<sup>18</sup>F]FDG uptake in axillary lymph nodes and deltoid muscle after COVID-19 mRNA vaccination: a cohort study t…
Kubota K; Saginoya T; Ishiwata K; Nakasato T; Munechika H.
Ann Nucl Med (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Prostate-specific membrane antigen and fibroblast activation protein distribution in prostate cancer: preliminary data …
Kessel K; Seifert R; Weckesser M; Boegemann M; Huss S; Kratochwil C; Haberkorn U; Giesel F; Rahbar K.
Ann Nucl Med (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
A design of forceps-type coincidence radiation detector for intraoperative LN diagnosis: clinical impact estimated from…
Takahashi M; Yoshimura S; Takyu S; Aikou S; Okumura Y; Yagi K; Fukayama M; Momose T; Seto Y; Yamaya T.
Ann Nucl Med (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Safety and efficacy of peptide receptor radionuclide therapy with <sup>177</sup>Lu-DOTA<sup>0</sup>-Tyr<sup>3</sup>-oct…
Kobayashi N; Takano S; Ito K; Sugiura M; Ogawa M; Takeda Y; Okubo N; Suzuki A; Tokuhisa M; Kaneta T; Utsunomiya D; Hata M; Inoue T; Hosono M; Kinuya S; Ichikawa Y.
Ann Nucl Med (Unknown)
Published: 2021
Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients.
Advani P; Chumsri S; Pai T; Li Z; Sharma A; Parent E.
Ann Nucl Med (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Optimization of injection dose in <sup>18</sup>F-FDG PET/CT based on the 2020 national diagnostic reference levels for …
Sagara H; Inoue K; Yaku H; Ohsawa A; Someya T; Yanagisawa K; Ohashi S; Ishigaki R; Wakabayashi M; Muramatsu Y; Fujii H.
Ann Nucl Med (Unknown)
Published: 2021
1/6 Transparent
Coronary plaque instability assessed by positron emission tomography and optical coherence tomography.
Galiuto L; Leccisotti L; Locorotondo G; Porto I; Burzotta F; Trani C; Niccoli G; Leone AM; Danza ML; Melita V; Fedele E; Stefanelli A; Giordano A; Crea F.
Ann Nucl Med (Unknown)
Published: 2021
3/6 Transparent
Funding Declared